Effectiveness of misoprostol administration for cervical ripening in women before operative hysteroscopy: a randomized, double-blinded controlled trial

被引:8
作者
Zhuo, Zhihong [1 ]
Yu, Huimin [1 ]
Gao, Li [1 ]
Jiang, Xingzhi [1 ]
机构
[1] Ningbo 2 Hosp, Ningbo 315010, Zhejiang, Peoples R China
关键词
Misoprostol; hysteroscopy; cervical ripening; oral; vaginal; VAGINAL MISOPROSTOL; PREMENOPAUSAL WOMEN; ORAL MISOPROSTOL; PHARMACOKINETICS; COMPLICATIONS; PREVENTION;
D O I
10.1080/13645706.2018.1559195
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To compare the effectiveness of misoprostol administration orally or vaginally for cervical ripening in women before operative hysteroscopy surgery. Material and methods: Two hundred seventy-five women eligible for operative hysteroscopy were recruited for a controlled, blinded, randomized trial. Twenty-two women were excluded from the study. Patients were randomly assigned to take 600??g of misoprostol or 30?mg vitamin B6 orally or vaginally, respectively, 4?12?h before operative hysteroscopy. Main outcome measures: Extent of cervical diameter before the hysteroscopy procedure, need for further cervical dilatation, degree of ease of cervical dilation, duration of additional cervix dilatation and hysteroscopy procedure, abdominal pain prior to surgical procedure, patients? acceptability, complications and associated side effects during the hysteroscopy procedures. Results: Cervical width in the vaginal and oral misoprostol groups after administration was 7.2???0.9?mm and 7.5???1.4?mm, respectively, a statistically significant difference compared to the control group. The duration required for cervical priming with misoprostol, either vaginally or orally (75???24?s or 82???22?s), was significantly shorter than that of placebo (148???31?s). The effect of cervical dilation with misoprostol was significantly higher in the premenopausal participants. Occurrence of uterine false tract substantially increased in the placebo group. Meanwhile, the risk of side-effects increased in the misoprostol-treated patients compared to the control group. Conclusions: The administration of misoprostol seemed more effective than the control for preoperative cervical priming in menstrual participants. Further large randomized controlled trials are needed to determine whether misoprostol could reduce complications with fewer side-effects and to establish whether misoprostol has a substantial cervical dilation effect on either premenopausal or postmenopausal patients.
引用
收藏
页码:344 / 350
页数:7
相关论文
共 32 条
[1]   Detection of benign intracavitary lesions in postmenopausal women with abnormal uterine bleeding: A prospective comparative study on outpatient hysteroscopy and blind biopsy [J].
Angioni, Stefano ;
Loddo, Alessandro ;
Milano, Francesca ;
Piras, Bruno ;
Minerba, Luigi ;
Melis, Gian Benedetto .
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2008, 15 (01) :87-91
[2]   Vaginal misoprostol for cervical priming before hysteroscopy in perimenopausal and postmenopausal women [J].
Barcaite, E ;
Bartusevicius, A ;
Railaite, DR ;
Nadisauskiene, R .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2005, 91 (02) :141-145
[3]   Cervical Priming Before Diagnostic Operative Hysteroscopy in Infertile Women: A Randomized, Double-Blind, Controlled Comparison of 2 Vaginal Misoprostol Doses [J].
Bastu, Ercan ;
Celik, Cem ;
Nehir, Asli ;
Dogan, Murat ;
Yuksel, Bahar ;
Ergun, Bulent .
INTERNATIONAL SURGERY, 2013, 98 (02) :140-144
[4]   Cervical ripening before operative hysteroscopy in premenopausal women: a randomized, double-blind, placebo-controlled comparison of vaginal and oral misoprostol [J].
Batukan, Cem ;
Ozgun, Mahmut T. ;
Ozcelik, Bulent ;
Aygen, Ercan ;
Sahin, Yilmaz ;
Turkyilmaz, Cagdas .
FERTILITY AND STERILITY, 2008, 89 (04) :966-973
[5]   Complications in hysteroscopy: prevention, treatment and legal risk [J].
Bradley, LD .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2002, 14 (04) :409-415
[6]   Prospective multicentre randomized controlled trial to evaluate factors influencing the success rate of office diagnostic hysteroscopy [J].
Campo, R ;
Molinas, CR ;
Rombauts, L ;
Mestdagh, G ;
Lauwers, M ;
Braekmans, P ;
Brosens, I ;
Van Belle, Y ;
Gordts, S .
HUMAN REPRODUCTION, 2005, 20 (01) :258-263
[7]   Misoprostol: A quarter century of use, abuse, and creative misuse [J].
Chong, YS ;
Su, LL ;
Arulkumaran, S .
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2004, 59 (02) :128-140
[8]   Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia - A systematic quantitative review [J].
Clark, TJ ;
Voit, D ;
Gupta, JK ;
Hyde, C ;
Song, FJ ;
Khan, KS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (13) :1610-1621
[9]   Use of misoprostol prior to hysteroscopy in postmenopausal women: A randomized, placebo-controlled clinical trial [J].
da Costa, Aurlio Ribeiro ;
Pinto-Neto, Aarao Mendes ;
Amorim, Melania ;
Paiva, Lucia Helena Simoes Costa ;
Scavuzzi, Adriana ;
Schettini, Juliana .
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2008, 15 (01) :67-73
[10]   Hysteroscopy and the treatment of uterine fibroids [J].
Emanuel, Mark Hans .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2015, 29 (07) :920-929